文献速递炎症性肠病

拉丁美洲和加勒比地区炎症性肠病进展:系统综述

Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-06-25

该系统综述检索了截至2018年9月的文献,分析61篇文章,发现拉丁美洲和加勒比地区炎症性肠病(IBD)的发病率和患病率持续上升,溃疡性结肠炎与克罗恩病比值除巴西外均大于1,抗TNF治疗在克罗恩病中增加而溃疡性结肠炎中较少,手术率随时间下降。

要点

  • 拉丁美洲和加勒比地区IBD发病率和患病率持续上升。
  • 除巴西外,所有地区溃疡性结肠炎与克罗恩病比值均大于1。
  • 克罗恩病抗TNF治疗增加,溃疡性结肠炎治疗增加较少,手术率下降。

核心结论

  • 系统综述发现拉丁美洲和加勒比地区IBD发病率呈上升趋势。

研究设计与样本

  • 检索MEDLINE、EMBASE和SciELO数据库截至2018年9月12日,纳入61篇关于克罗恩病或溃疡性结肠炎的临床或流行病学研究。

主要发现

  • 巴西克罗恩病发病率从1988年0.08/10万人年升至1991-1995年0.68/10万人年,2015年达5.5/10万人年。
  • 2007年阿根廷报告IBD最高患病率:克罗恩病15/10万人年,溃疡性结肠炎82/10万人年。
  • 除巴西外,拉丁美洲和加勒比所有地区溃疡性结肠炎与克罗恩病比值均大于1。
  • 巴西2014年克罗恩病患者43.4%接受抗TNF治疗,溃疡性结肠炎患者4.5%接受抗TNF治疗。
  • 智利1990-2002年克罗恩病手术率57.0%、溃疡性结肠炎18.0%,2012-2015年分别降至38.0%和5.0%。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The incidence of inflammatory bowel diseases (IBD) is increasing in Latin America. We performed a systematic review to identify clinical and epidemiologic features of IBD in Latin America (including Mexico, Central America, and South America) and the Caribbean. METHODS: We searched MEDLINE, EMBASE, and SciELO databases for clinical or epidemiologic studies of Crohn's disease (CD) or ulcerative colitis (UC) from Latin American and Caribbean countries and territories that reported incidence, prevalence, ratio of UC:CD, IBD phenotype, and treatment, through September 12, 2018. Data were extracted from 61 articles for analysis. RESULTS: The incidence and prevalence of IBD have been steadily increasing in Latin America and the Caribbean. The incidence of CD in Brazil increased from 0.08 per 100,000 person-years in 1988 to 0.68 per 100,000 person-years in 1991-1995 to 5.5 per 100,000 person-years in 2015. The highest reported prevalence of IBD was in Argentina, in 2007, at 15 and 82 per 100,000 person-years for CD and UC, respectively. The ratio of UC:CD exceeded 1 in all regions throughout Latin America and the Caribbean with the exception of Brazil. Treatment with tumor necrosis factor antagonists increased steadily for patients with CD (43.4% of all patients in Brazil were treated in 2014) but less so for patients with UC (4.5% of all patients were treated in 2014). Surgery for IBD decreased with time. In Chile, surgeries were performed on 57.0% of patients with CD and 18.0% of patients with UC during the period of 1990-2002; these values decreased to 38.0% and 5.0%, respectively, during the period of 2012-2015. In Peru, 6.9% of patients with UC received colectomies in the period of 2001-2003 and 6.2% in 2004-2014. CONCLUSIONS: In a systematic review, we found the incidence of IBD to be increasing throughout Latin America and the Caribbean. Population-based epidemiology studies are needed to evaluate the increase in IBD in these regions, which differ from other global regions in climate, culture, demographics, diet, healthcare delivery and infrastructure, and socioeconomic status.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Kotze PG, Underwood FE, Damião AOMC, et al. Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review. Clin Gastroenterol Hepatol. 2019. PMID: 31252191. doi:10.1016/j.cgh.2019.06.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。